Scarica l'app Stockscreener
11.08
0.91%
0.10
Dopo l'orario di chiusura:
11.10
0.02
+0.18%
Precedente Chiudi:
$10.98
Aprire:
$11.18
Volume 24 ore:
488.39K
Relative Volume:
0.43
Capitalizzazione di mercato:
$1.49B
Reddito:
$1.12B
Utile/perdita netta:
$5.00M
Rapporto P/E:
1,108.00
EPS:
0.01
Flusso di cassa netto:
$-383.00M
1 W Prestazione:
-7.51%
1M Prestazione:
+14.34%
6M Prestazione:
+8.10%
1 anno Prestazione:
-38.00%
Intervallo 1D:
$10.95
$11.30
Intervallo di 1 settimana:
$10.91
$12.26
Portata 52W:
$7.33
$18.59
Indivior Plc Stock (INDV) Company Profile
Nome
Indivior Plc
Settore
Telefono
804-379-1090
Indirizzo
234 BATH ROAD, SLOUGH, BERKSHIRE
Confronta INDV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INDV
Indivior Plc
|
11.08 | 1.49B | 1.12B | 5.00M | -383.00M | 0.01 |
|
ZTS
Zoetis Inc
|
159.27 | 70.23B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.74 | 48.23B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.36 | 48.22B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.93 | 18.57B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.42 | 13.29B | 2.76B | 1.11B | 898.10M | 22.77 |
Indivior Plc Stock (INDV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-28 | Iniziato | Rodman & Renshaw | Buy |
| 2024-07-23 | Iniziato | Piper Sandler | Overweight |
| 2024-04-03 | Iniziato | Craig Hallum | Buy |
| 2023-07-13 | Iniziato | Northland Capital | Outperform |
Indivior Plc Borsa (INDV) Ultime notizie
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Indivior PLC (INDV) - ACCESS Newswire
Indivior PLC Announces AGM Results with Key Resolutions Passed - TipRanks
Indivior PLC Sued for Securities Law ViolationsContact Levi & Korsinsky Before October 1, 2024 to Discuss Your Rights – INDV - ACCESS Newswire
Indivior PLC announces leadership and bylaw changes - Investing.com Australia
Indivior PLC announces leadership and bylaw changes By Investing.com - Investing.com Nigeria
Indivior PLC Announces Successful AGM Resolutions - TipRanks
Naloxone Market Set to Witness Significant Growth by 2025-2032 | - openPR.com
Investors who lost money on Indivior PLC (INDV) should contact Levi & Korsinsky about pending Class ActionINDV - ACCESS Newswire
Decoding Indivior PLC (INDV): A Strategic SWOT Insight - GuruFocus
Shareholders that lost money on Indivior PLC (INDV) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
When (INDV) Moves Investors should Listen - news.stocktradersdaily.com
New Study Highlights Monthly SUBLOCADE® as a Potential Treatment Option for Opioid Use Disorder During and After Pregnancy - The Malaysian Reserve
INDIVIOR PLC SEC 10-Q Report - TradingView
Indivior PLC Announces Total Voting Rights and Share Capital Update - TipRanks
Opioid Antagonist Market Is Booming Worldwide 2025-2032 | - openPR.com
Drug Detoxification Market Is Booming Worldwide 2025-2032 | - openPR.com
Evolving Landscape of Mental Health Segment: Key Market Insights of the Latest Published Substance Use Disorders Report — Alcohol Use Disorder, Cocaine Use Disorder, Opioid Use Disorder, and Cannabis Use Disorder | DelveInsight - GlobeNewswire Inc.
Indivior: Trying To Break Addiction (NASDAQ:INDV) - Seeking Alpha
Results: Indivior PLC Exceeded Expectations And The Consensus Has Updated Its Estimates - simplywall.st
Indivior PLC Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Yahoo Finance
Press Release Distribution & PR Platform - ACCESS Newswire
Indivior to release Q4 and full-year 2024 results on Feb 20 - MSN
Indivior Reports Q1 2025 Results, Maintains FY Guidance Amid Market Challenges - MSN
Indivior PLC (INDV) Trading 3.9% Higher on Apr 25 - GuruFocus
Indivior Announces Q1 2025 Financial Results - The Malaysian Reserve
Indivior Faces Revenue Challenges Amid Competitive Pressures - TipRanks
Indivior Q1 2025 Earnings Call Transcript - MarketBeat
Indivior (INDV) Q1 2025 Earnings Call - Mitrade
FTSE 250 movers: Indivior surges; Inchcape slips - Sharecast.com
Indivior PLC (INDV) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
Indivior PLC Q1 2025 Earnings: EPS of $0.38 Beats Estimate, Revenue Hits $266 Million - GuruFocus
Indivior Q1 2025 Financial Results - TradingView
Indivior (INDV) Surpasses Q1 Revenue Projections with $266M Repo - GuruFocus
Indivior shares surge following robust Q1 revenue and positive outlook By Investing.com - Investing.com Nigeria
Indivior Announces Q1 2025 Financial Results | INDV Stock News - GuruFocus
A Look at Indivior's Upcoming Earnings Report - Benzinga
Indo-Asian News Service-INDIVIOR ANNOUNCES Q1 2025 FINANCIAL RESULTS - Indo-Asian News Service (IANS)
In the wake of Indivior PLC's (LON:INDV) latest UK£44m market cap drop, institutional owners may be forced to take severe actions - simplywall.st
U.S. Opioid Withdrawal Treatment Market Emerging Trends - openPR.com
Indivior Plc Azioni (INDV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.82%
1.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):